ALEAF (Aleafia Health) Research & Development: $0.00 Mil (TTM As of Mar. 2023)


ALEAF Aleafia Health Inc ALEAF
12 GF Score
Price $0.00
View Full Analysis

What is Aleafia Health Research & Development?

Aleafia Health ALEAF -99.00% 12 Research & Development is $0.00 Mil as of Mar. 2023. GuruFocus rates ALEAF with a GF Score™ of 12/100.

Research & Development is the aggregate amount of research and development expenses during the year. Aleafia Health's Research & Development for the three months ended in Mar. 2023 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 was $0.00 Mil.

Aleafia Health  (GREY:ALEAF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Aleafia Health Research & Development Related Terms

Aleafia Health Research & Development Historical Data

* Premium members only.

The historical data trend for Aleafia Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aleafia Health Research & Development Chart

Aleafia Health Annual Data
Trend Jan12 Jan13 Jan14 Jan15 Jan16 Oct17 Dec18 Dec19 Dec20 Mar23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Aleafia Health Quarterly Data
Oct17 Jan18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Jun22 Sep22 Dec22 Mar23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
ALEAF
12GF Score
Aleafia Health Inc ALEAF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aleafia Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Mar. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Aleafia Health (ALEAF) has a Research & Development of $0.00 Mil as of Mar. 2023. Research and development expense is the total cost for research and development activities. View historical data on Aleafia Health and its competitors.
Is Aleafia Health's Research & Development too high?
Aleafia Health's current Research & Development is $0.00 Mil. Overall, Aleafia Health has a GF Score™ of 12/100, reflecting its overall financial health beyond just this single metric.
How does Aleafia Health's Research & Development compare to ZTS and CTLT?
Aleafia Health's Research & Development of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Aleafia Health and its competitors. Aleafia Health's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aleafia Health stock overvalued right now?
Aleafia Health (ALEAF) has a current Research & Development of $0.00 Mil. The current Research & Development is $0.00 Mil. Aleafia Health's overall GF Score™ is 12/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Aleafia Health (ALEAF), the current Research & Development is $0.00 Mil as of Mar. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aleafia Health Business Description

Address 85 Basaltic Road, Concord, ON, CAN, L4K 1G4
Aleafia Health Inc is a vertically integrated cannabis health and wellness company which owns three cannabis product and cultivation facilities where it produces a diverse portfolio of commercially high-margin derivative products including oils, capsules and sprays.
12GF Score

Get the complete analysis for ALEAF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.00
Price